The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data.
about
The Patient's Guide to Psoriasis Treatment. Part 1: UVB PhototherapyManagement of atopic dermatitis: safety and efficacy of phototherapyEpidemiology of basal cell carcinoma: scholarly review.Porcine skin as a model system for studies of adverse effects of narrow-band UVB pulses on human skin.Vitiligo therapy in children: a case for considering excimer laser treatment.Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.Differential effects of 5-aminolaevulinic acid photodynamic therapy and psoralen + ultraviolet A therapy on p53 phosphorylation in normal human skin in vivo.Basal cell carcinoma: review of epidemiology, pathogenesis, and associated risk factors.The treatment of severe atopic dermatitis in childhood with narrowband ultraviolet B phototherapy.Mycosis fungoides patient accompanied actinic keratosis, actinic keratosis with squamous cell carcinoma transformation, and porokeratosis after NBUVB therapy - 1st case report and review of the literatureA review of monochromatic excimer light in vitiligo.The Safety and Efficacy of Narrow Band Ultraviolet B Treatment in Dermatology: A Review.Dermoscopic Changes of Melanocytic Nevi after Psoralen-Ultraviolet A and Narrow-Band Ultraviolet B PhototherapyExploring the gaps in the evidence-based application of narrowband UVB for the treatment of vitiligo.Modern aspects of phototherapy for atopic dermatitis.Melanoma and non-melanoma skin cancer in psoriatic patients treated with high-dose phototherapy.Skin cancer in the end-stage renal disease population: unique risk factors for patients on dialysis.What is the most common phototherapy prescription for psoriasis: NB-UVB or PUVA? Prescription behavior.The challenge of follow-up in narrowband ultraviolet B phototherapy.Updates from the British Association of Dermatologists 85th annual meeting, 5-8 July 2005, Glasgow, U.K.
P2860
Q26740460-BE74CCEB-DFB1-4C72-8E64-AF28F5935EBDQ26778443-6B873349-D85A-4B9F-A694-2C04A3D03B9EQ30235834-0F028D37-B746-4194-B94E-6E40BDE81FAEQ33474954-60E69396-6547-49FA-9A29-E5D30E2427A0Q33544105-7FC05F7B-EF90-4239-82FE-20FCDC46FFE5Q34237352-6D16AFF9-F0D9-4F6E-A59F-2DEF30BFAAA8Q34449302-0933C28F-A5B5-414E-B554-D77BCF19D1E5Q34459620-03AB5E02-8BD6-4CF9-9389-0432B2A2ADF8Q36726758-098FAADF-D952-484C-91EA-8B6CB552E772Q36738164-3E7B4385-4F24-4338-B487-2D9A583FA83CQ37354775-04FEF994-F3A0-415E-BE40-77624543027FQ38004595-8E5283D8-0B17-4A2E-B252-12D084E68E48Q38586623-C5BBA7EA-C4E0-4836-AD93-50B0C657E6D6Q38596686-E09D71A3-3FF2-41DB-951B-2165E89A8187Q38668078-A3D8F8DA-CA2E-462D-B9CB-91CB54AE6812Q40008863-4125ACDA-C842-4871-BC81-69ACE26C7E3AQ40046640-C1D81353-7A06-48F3-9FD8-D6D16557B6DAQ40416390-07324429-0AFB-40C9-A0CC-FBB87A51A26BQ43294646-AEEA1118-14D5-4763-8504-F1FF42D6B2C1Q43926982-87D3F93B-0F0E-4502-AB25-6A348DBDA1F0Q50782275-CBC6E518-E1FD-46E5-9518-88005447BE04
P2860
The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data.
@ast
The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data.
@en
type
label
The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data.
@ast
The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data.
@en
prefLabel
The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data.
@ast
The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data.
@en
P2093
P2860
P1476
The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data
@en
P2093
P2860
P304
P356
10.1111/J.1365-2133.2005.06537.X
P407
P577
2005-04-01T00:00:00Z